Comparison · NCT04514341-21a554c2
Group 1 vs Group 2: Impact of Remote Patient Navigation Services
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Group 1 vs Group 2: Impact of Remote Patient Navigation Services. Trial comparisons, record NCT04514341-21a554c2. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04514341-21a554c2
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.398 | 0.372 | 0.424 | wilson | |
| Risk in group 2 | 0.252 | 0.228 | 0.278 | wilson | |
| Risk difference, group 1 minus group 2 | 0.146 | 0.109 | 0.182 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.58 | 1.4 | 1.78 | log | |
| Odds ratio, group 1 over group 2 | 1.96 | 1.65 | 2.33 | log | |
| Number needed to treat, for one more participant with the outcome on Group 1 than on Group 2 | 6.86 | 5.5 | 9.18 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Group 1 | The study was conducted in four federally qualified health centers (FQHCs): two in Illinois and two in Indiana. One FQHC from Illinois and one from Indiana were randomly assigned to Group 1, and the remaining two formed Group 2. Both groups received all intervention components except that Group 2 began the intervention three months later than Group 1.~The intervention consists of three components:~1. Provider and staff education,~2. Patient reminders using short message services (SMS), and~3. Remote patient navigation (PN).~Implementation was phased as follows:~* Phase 0: No intervention components~* Phase 1: Component 1 only~* Phase 2: Components 1 + 2~* Phase 3: Components 1 + 2 +3 | 529 | 1,330 | OG000 |
| Group 2 | Group 2 | The study was conducted in four federally qualified health centers (FQHCs): two in Illinois and two in Indiana. One FQHC from Illinois and one from Indiana were randomly assigned to Group 1, and the remaining two formed Group 2. Both groups received all intervention components except that Group 2 began the intervention three months later than Group 1.~The intervention consists of three components:~1. Provider and staff education,~2. Patient reminders using short message services (SMS), and~3. Remote patient navigation (PN).~Implementation was phased as follows:~* Phase 0: No intervention components~* Phase 1: Component 1 only~* Phase 2: Components 1 + 2~* Phase 3: Components 1 + 2 +3 | 284 | 1,127 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Impact of Remote Patient Navigation Services
- Description
- The number of participants who received remote navigation services (phone-based navigation) during Phase 3 and subsequently completed their screenings.
- Time frame
- From the navigation service initiated at the partner FQHC until the completion of the study, assessed up to 16 months.
- Population
- The overall number represents the number of participants whom the navigators successfully contacted and spoke to during Phase 3.
Source ClinicalTrials.gov
Trial
- Title
- Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
- NCT number
- NCT04514341
- Phases
- Conditions
- Colorectal Cancer
- Interventions
Intervention Phase 1: Provider and Staff education, Intervention Phase 2: Provider and staff education + Patient reminder, Intervention Phase 3: Provider and Staff education + Patient reminder + Patient navigation
- Lead sponsor
- Milton S. Hershey Medical Center
- Results first posted
- 2026-01-14
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04514341?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04514341-21a554c2